Friday, December 1, 2017

New Treatment for T-cell Lymphomas

       In an article published on ScienceDaily, it discusses new innovations in cancer research. The research was based off of Lymphomas, which is the cancer among immune cells, or lymphocytes.  
T-cells and B-cells are two particular lymphocytes that when they become malignant, cause a lymphoma. T-cell lymphomas are much more difficult to treat because the treatment will not only kill the malignant T-cells, but it will kill the healthy T-cells as well. T-cells are vital for the body because they prevent infections. When a normal T-cell recognizes an infectious bacteria in the body, the eliminate with their T-cell receptor. It's receptor has one of the two replicated copies of the T-cell receptor gene, which could be either C1 or C2. Researchers have figured out that in T-cell lymphomas, either all of the C1 gene, or all of the C2 genes are malignant. Researchers were able to then able to figure out a way of how to kill all of the malignant C1 or C2 genes, while sparing whichever gene is not affected by the cancer. While there is still much more research to be done, I believe that the findings will revolutionize medicine and lead to many more cancer-related breakthroughs.

No comments:

Post a Comment